- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01321632
Efficacy of Zingiber Officinalis (Homoeopathic Medicine) in Treatment of Acne Vulgaris
October 21, 2012 updated by: Dr. Anjali Miglani, Miglani, Anjali
Efficacy of Lesser Known Homoeopathic Medicines in Acne Vulgaris - Zingiber Officinalis
Acne is one of the most common skin problems in teenagers and adolescents.
There are many lesser known homoeopathic medicines which have been mentioned in the literature for treatment of acne but their potential has not been properly assessed /documented and therefore these medicines don't form a part of many prescriptions.
As a part of this study, efficacy of Zingiber officinalis will be studied in the treatment of Acne vulgaris
Study Overview
Study Type
Interventional
Enrollment (Actual)
32
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Delhi
-
New Delhi, Delhi, India, 110075
- Delhi Government Health Centre - Homoeopathic Dispensary - Sector 12, Dwarka
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
12 years to 25 years (ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Males and females between 12 to 25 years of age
- Presence of inflammatory and non-inflammatory lesions
- Able to follow-up according to protocol
- Patients not taking any medication for treatment of Acne in preceding one month.
Exclusion Criteria:
- Acne Conglobata
- Pregnant or Breast feeding females or females having intention of becoming pregnant
- Significant systemic disease
- Any drug/ alcohol addiction
- History of chronic diseases treated with medications in the preceding month which might affect acne condition and treatment outcome
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
percent change in acne lesion counts from the Baseline
Time Frame: 6 months
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
change in quality of life of subjects from baseline
Time Frame: 6 months
|
Change in Quality of life will be assessed based on Quality of Life Questionnaire to be filled by subjects at the start of Treatment and at the end of time frame.
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2011
Primary Completion (ACTUAL)
June 1, 2012
Study Completion (ACTUAL)
July 1, 2012
Study Registration Dates
First Submitted
March 20, 2011
First Submitted That Met QC Criteria
March 22, 2011
First Posted (ESTIMATE)
March 23, 2011
Study Record Updates
Last Update Posted (ESTIMATE)
October 23, 2012
Last Update Submitted That Met QC Criteria
October 21, 2012
Last Verified
October 1, 2012
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Acne-002
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acne Vulgaris
-
Galderma R&DCompletedSevere Acne VulgarisUnited States, Canada, Puerto Rico
-
Sebacia, Inc.CompletedInflammatory Acne VulgarisUnited States
-
Nexgen Dermatologics, Inc.Unknown
-
Rejuva Medical AestheticsHealMD, LLCNot yet recruitingAcne Vulgaris (Disorder)United States
-
InMode MD Ltd.Active, not recruitingInflammatory Acne VulgarisUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingModerate to Severe Acne VulgarisChina
-
PollogenLumenis Be Ltd.RecruitingModerate to Severe Acne VulgarisUnited States
-
Boston PharmaceuticalsCompletedModerate to Severe Acne VulgarisUnited States, Canada
-
Bispebjerg HospitalCompleted
-
Actavis Mid-Atlantic LLCCompletedMILD TO SEVERE ACNE VULGARISIndia
Clinical Trials on Zingiber officinalis
-
Gordon SaxeUniversity of California, Los Angeles; University of California, IrvineActive, not recruiting
-
Mahidol UniversityUnknown
-
Oregon Health and Science UniversityNational Center for Complementary and Integrative Health (NCCIH)CompletedAlzheimer DiseaseUnited States
-
Shahid Beheshti UniversityCompletedAcute Respiratory Distress SyndromeIran, Islamic Republic of
-
Chonbuk National University HospitalCompleted
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedFatigue | Unspecified Adult Solid Tumor, Protocol Specific | Sleep DisordersUnited States
-
Ain Shams UniversityCompleted
-
Azienda di Servizi alla Persona di PaviaCompleted